![19th Conference of the International Society of Geriatric Oncology](http://media.vumedi.com/thumbs/channel_logo/2019/10/a2aa5c30-39f1-4433-9e39-755b2936fd90.jpg.200x0_q85.jpg)
Breast
19th Conference of the International Society of Geriatric Oncology
Serious Adverse Events Among Older Patients in the ALTTO Trial Comparing Anti-HER2 w/ Lapatinib & Trastuzumab, Their sequence or Combination in the Adjuvant Treatment of HER2+ Early Breast Cancer
FEATURING
Lissandra Dal Lago
- 20 views
- December 27, 2019